Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02432274
Title Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eisai Limited
Indications

osteosarcoma

thyroid gland cancer

Advanced Solid Tumor

Therapies

Etoposide

Lenvatinib

Cyclophosphamide

Age Groups: child
Covered Countries USA


No variant requirements are available.